Skip to main content
Have a personal or library account? Click to login
An Innovative Time Series Approach to Dynamic Population Modeling for Tobacco Harm Reduction Assessment Cover

An Innovative Time Series Approach to Dynamic Population Modeling for Tobacco Harm Reduction Assessment

Open Access
|Oct 2026

References

  1. Bachand, A.M. and S.I. Sulsky: A Dynamic Population Model for Estimating All-Cause Mortality Due to Lifetime Exposure History; Regul. Toxicol. Pharmacol. 67 (2013) 246–251. DOI: 10.1016/j.yrtph.2013.08.003. Erratum in: Regul Toxicol Pharmacol. 90 (2017) 364. DOI: 10.1016/j.yrtph.2017.09.024
  2. Hill, A. and O.M. Camacho: A System Dynamics Modelling Approach to Assess the Impact of Launching a New Nicotine Product on Population Health Outcomes; Regul. Toxicol. Pharmacol. 86 (2017) 265–278. DOI: 10.1016/j.yrtph.2017.03.012
  3. Levy, D.T., K.M. Cummings, A.C. Villanti, R. Niaura, D.B. Abrams, G.T. Fong, and R. Borland: A Framework for Evaluating the Public Health Impact of E-Cigarettes and Other Vaporized Nicotine Products; Addiction 112 (2017) 8–17. DOI: 10.1111/add.13394. Erratum in: Addiction. 119 (2024) 1663. DOI: 10.1111/add.16603
  4. Poland, B. and F. Teischinger: Population Modeling of Modified Risk Tobacco Products Accounting for Smoking Reduction and Gradual Transitions of Relative Risk; Nicotine Tob. Res. 19 (2017) 1277–1283. DOI: 10.1093/ntr/ntx070.
  5. Djurdjevic, S., P.N. Lee, R. Weitkunat, Z. Sponsiello-Wang, F. Lüdicke, and G. Baker: Modeling the Population Health Impact of Introducing a Modified Risk Tobacco Product into the U.S. Market; Healthcare 6 (2018) 47. DOI: 10.3390/healthcare6020047
  6. Djurdjevic, S., Z. Sponsiello-Wang, P.N. Lee, J.S. Fry, R. Weitkunat, F. Lüdicke, and G. Baker: Modeling the Impact of Changes in Tobacco Use on Individual Disease Risks; Regul. Toxicol. Pharmacol. 97 (2018) 88–97. DOI: 10.1016/j.yrtph.2018.06.001
  7. Bachand, A.M., S.I. Sulsky, and G.M. Curtin: Assessing the Likelihood and Magnitude of a Population Health Benefit Following the Market Introduction of a Modified-Risk Tobacco Product; Risk Anal. 38 (2018) 151–162. DOI: 10.1111/risa.12819
  8. Levy, D.T., R. Borland, E.N. Lindblom, M.L. Goniewicz, R. Meza, T.R. Holford, Z. Yuan, Y. Luo, R.J. O'Connor, R. Niaura, and D.B. Abrams: Potential Deaths Averted in USA by Replacing Cigarettes with E-Cigarettes; Tob. Control 27 (2018) 18–25. DOI: 10.1136/tobaccocontrol-2017-053759
  9. Lee, P.N., J.S. Fry, S. Gilliland III, P. Campbell, and A.R. Joyce: Estimating the Reduction in US Mortality if Cigarettes Were Largely Replaced by E-Cigarettes; Arch. Toxicol. 96 (2022) 167–176. DOI: 10.1007/s00204-021-03180-3
  10. United States Department of Health and Human Services (HHS): Population Assessment of Tobacco and Health (PATH) Study Public-Use Files; ICPSR, Ann Arbor, MI (2025). DOI: 10.3886/ICPSR36498.v23
  11. Muhammad-Kah, R.S., T. Hannel, L. Wei, Y.B. Pithawalla, and M. Gogova: A Computational Model Assessing Population Impact of a New Tobacco Product; Qeios (2023). DOI: 10.32388/TVND4Q
  12. Hannel, T., L. Wei, R. Muhammad-Kah, E.G. Largo, and M.A. Sarkar: Modeling the Population Health Impact of Accurate and Inaccurate Perceptions of Harm from Nicotine; Harm Reduct. J. 21 (2024) 145. DOI: 10.1186/s12954-024-01059
  13. Wissmann, R., C. Zhan, K. D'Amica, S. Prakash, and Y. Xu: Modeling the Population Health Impact of ENDS in the U.S.; Am. J. Health Behav. 45 (2021) 588–610. DOI: 10.5993/AJHB.45.3.12
  14. Taylor, S.J. and B. Letham: Forecasting at Scale; The American Statistician 72 (2018) 37–45. DOI: 10.1080/00031305.2017.1380080
  15. Taylor, S.J. and B. Letham: Forecasting at Scale; Am. Stat. 72 (2018) 37–45.
  16. The R Core Team: R: A Language and Environment for Statistical Computing; R Foundation for Statistical Computing, Vienna, Austria (2023). Available at: https://www.r-project.org/
  17. RStudio Team: RStudio Server: Integrated Development Environment for R; RStudio, Boston, MA, USA (2023).
  18. Wickham, H., M. Averick, J. Bryan, W. Chang, L.D. McGowan, R. François, G. Grolemund, A. Hayes, L. Henry, J. Hester, M. Kuhn, T.L. Pedersen, E. Miller, S.M. Bache, K. Müller, J. Ooms, D. Robinson, D.P. Seidel, V. Spinu, K. Takahashi, D. Vaughan, C. Wilke, K. Woo, and H. Yutani: Welcome to the Tidyverse; J. Open Source Softw. 43 (2019) 1686. DOI: 10.21105/joss.01686
  19. Institute of Medicine (IOM): Public Health Implications of Raising the Minimum Age of Legal Access to Tobacco Products; edited by R.J. Bonnie, K. Stratton, and L.Y. Kwan, The National Academies Press, Washington, DC, USA, 2015, 398 pp. Available at: https://www.nationalacademies.org/publications/18997 (accessed October 2026). DOI: 10.17226/18997
  20. Tam, J., D.T. Levy, J. Jeon, J. Clarke, S. Gilkeson, T. Hall, E.J. Feuer, T.R. Holford, and R. Meza: Projecting the Effects of Tobacco Control Policies in the USA Through Microsimulation; BMJ Open 8 (2018) e019169. DOI: 10.1136/bmjopen-2017-019169
  21. Rogers, R.G., R.A. Hummer, P.M. Krueger, and F.C. Pampel: Combining Prevalence and Mortality Risk Rates: The Case of Cigarette Smoking; Popul. Dev. Rev. 31 (2005) 259–292. DOI: 10.1111/j.1728-4457.2005.00065.x.
  22. U.S. Centers for Disease Control and Prevention (CDC): National Health Interview Survey Public Use Data Files 2016–2024; CDC, Altlanta, GA, USA, 2024.
  23. Nutt, D.J., L.D. Phillips, D. Balfour, H.V. Curran, M. Dockrell, J. Foulds, K. Fagerström, K. Letlape, R. Polosa, J. Ramsey, and D. Sweanor: E-Cigarettes Are Less Harmful Than Smoking; Lancet 387 (2016) 1160–1162. DOI: 10.1016/S0140-6736(15)00253-6
  24. McNeill, A., L.S. Brose, R. Calder, L. Bauld, and D. Robson: Evidence Review of E-Cigarettes and Heated Tobacco Products 2018. A Report Commissioned by Public Health England; Public Health England, London, UK, 2018, 243 pp. Available at: https://www.gov.uk/government/publications/e-cigarettes-and-heated-tobacco-products-evidence-review/evidence-review-of-e-cigarettes-and-heated-tobacco-products-2018-executive-summary (accessed October 2026).
  25. Weitkunat, R., P.N. Lee, G. Baker, Z. Sponsiello-Wang, A.M. González-Zuloeta Ladd, and F. Lüdicke: A Novel Approach to Assess the Population Health Impact of Introducing a Modified Risk Tobacco Product; Regul. Toxicol. Pharmacol. 72 (2015) 87–93. DOI: 10.1016/j.yrtph.2015.03.011
  26. Lee, P.N., J.S. Fry, J.F. Hamling, Z. Sponsiello-Wang, G. Baker, and R. Weitkunat: Estimating the Effect of Differing Assumptions on the Population Health Impact of Introducing a Reduced Risk Tobacco Product in the USA; Regul. Toxicol. Pharmacol. 88 (2017) 192–213. DOI: 10.1016/j.yrtph.2017.06.009
  27. UK Office for National Statistics (ONS): E-Cigarette Use in Great Britain, 2014–2022; Office for National Statistics (2024). Available at: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/drugusealcoholandsmoking/datasets/ecigaretteuseingreatbritain (accessed October 2026).
  28. Apelberg, B.J., S.P. Feirman, E. Salazar, C.G. Corey, B.K. Ambrose, A. Paredes, E. Richman, S.J. Verzi, E.D. Vugrin, N.S. Brodsky, and B.L. Rostron: Potential Public Health Effects of Reducing Nicotine Levels in Cigarettes in the United States; N. Engl. J. Med. 378 (2018) 1725–1733. DOI: 10.1056/NEJMsr1714617
  29. Warner, K.E. and D. Mendez: E-Cigarettes: Comparing the Possible Risks of Increasing Smoking Initiation with the Potential Benefits of Increasing Smoking Cessation; Nicotine Tob. Res. 21 (2019) 41–47. DOI: 10.1093/ntr/nty062
  30. GBD 2019 Chewing Tobacco Collaborators: Spatial, Temporal, and Demographic Patterns in Smoking Prevalence and Attributable Disease Burden, 1990–2019; Lancet 397 (2021) 2337–2360. DOI: 10.1016/S0140-6736(21)01169-7
DOI: https://doi.org/10.2478/cttr-2026-0014 | Journal eISSN: 2719-9509 (formerly 1612-9237)
Language: English, French, German
Page range: 197 - 205
Submitted on: Apr 1, 2026
Accepted on: Jun 15, 2026
Published on: Oct 25, 2026
Published by: Beiträge zur Tabakforschung GmbH
In partnership with: Paradigm Publishing Services

© 2026 Thomas Verron, Mengran Guo, Libby Clarke, Thomas Nahde, Xavier Cahours, published by Beiträge zur Tabakforschung GmbH
This work is licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License.